Weil advises on Argon Medical financing

Weil is advising Shandong Weigao Group Medical Polymer Company Limited (Weigao) and Argon Medical Devices Holdings, Inc. (Argon) on the refinancing of Argon’s existing debt. Argon is a U.S.-based manufacturer of medical devices and was acquired by Weigao, a Chinese developer, manufacturer and seller of single-use medical devices, in 2018. The refinancing comprises a New York law senior secured $375 million Tranche A Term and Revolver Facilities and an English law senior secured $75 million Tranche B Term Facility, which were marketed to lenders in the U.S. and Europe, respectively.

The Weil team is led by Hong Kong banking and finance partner Soo-Jin Shim and includes associates Kevin Yao, Rick Wei, Carolyn Ho and Max Maisonrouge.